June 2017 FDA Recall Drug by Fagron Compounding Services Llc Dba Fagron Sterile Services
D-0946-2017 - Lack Of Assurance Of Sterility

This Class II drug recall was voluntarily initiated by Fagron Compounding Services Llc Dba Fagron Sterile Services on June 19, 2017 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0946-2017

Reason for Recall
Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier
Initiated
06-19-2017
Reported
07-12-2017
Quantity
1,056 5mL syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fagron Compounding Services LLC dba Fagron Sterile Services
Nationwide in the USA
Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe. IV Use Only. JCB Laboratories, 8710 E 34th St., N. Wichita, KS 67226 UPC 7335968405

Batch or Lot Expiration Information

Lot# : C274-000000331, BUD 08/30/2017; C274-000001274, BUD 09/07/2017; C274-000001326, BUD 09/14/2017